• EPZ-6438: An EZH2 Inhibitor for Resistance Biology

  2026-09-11

  EPZ-6438 is a selective EZH2 inhibitor for dissecting H3K27me3-dependent transcription and treatment resistance. This guide connects chromatin pharmacology with time-resolved melanoma assays, lymphoma models, and practical experimental design.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-11

  Shapira-Netanelov and colleagues developed gastric cancer assembloids by combining patient-matched tumor organoids with stromal cell subpopulations derived from the same tumor. The model reproduced tumor–stroma effects on gene expression and drug sensitivity, offering a more physiologically relevant framework for resistance studies and personalized treatment research.

• Phenacetin: Structure, Solubility, and Research Use

  2026-09-10

  Phenacetin, also called N-(4-ethoxyphenyl)acetamide, is a historically used non-opioid analgesic and antipyretic with no established anti-inflammatory action. Its defined identity, solvent-dependent solubility, analytical quality data, and safety limitations make it relevant to controlled scientific research use and pharmacokinetic studies.

• 5-(N,N-dimethyl)-Amiloride in Endothelial Research

  2026-09-10

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to connect Na+/H+ exchanger activity with intracellular pH regulation, endothelial barrier failure, and cardiac ion-transport phenotypes. This workflow pairs a reversible pharmacological perturbation with moesin, permeability, sodium, and signaling readouts for more informative sepsis and ischemia-reperfusion injury studies.

• NLRP3 Astrocyte Phenotypes in Morphine Tolerance

  2026-09-09

  Yuan et al. link spinal NLRP3 inflammasome activation with a shift toward the neurotoxic A1 astrocyte phenotype during morphine tolerance. Pharmacological inhibition with MCC950 slowed tolerance development and normalized inflammatory and astrocyte-associated markers, providing a mechanistic framework for studying glia-driven opioid adaptation.

• MRSA Vesicles, IL-8, and Oral Cancer Progression

  2026-09-09

  A 2026 study identifies extracellular vesicles from methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma growth, rather than passive products of infection. Its experiments connect vesicle uptake with ERK/c-Jun activation, IL-8 production, CXCR1 signaling, CCL2 output, and JAK/STAT5A-dependent proliferation, providing a mechanistic framework for studying infection-associated tumor progression.

• Carbapenemase Gene Transmission in Guangdong CREC

  2026-09-08

  Chen et al. characterize carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae collected from eight teaching hospitals in Guangdong during 2022–2024. By combining gene localization, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR, the study links plasmid carriage with multidrug resistance and substantial horizontal-transfer potential.

• Methoxy-X04 for Amyloid Plaque Imaging Workflows

  2026-09-08

  Methoxy-X04 combines blood-brain barrier permeability with high-affinity amyloid labeling, supporting both in vivo plaque mapping and controlled tissue assays. This workflow-focused guide shows how to use the fluorescent amyloid beta probe to evaluate plaque clearance, microglial interventions, and cerebrovascular amyloid while avoiding common interpretation and handling errors.

• Decitabine Priming Expands CD8+ Progenitor Tex

  2026-09-07

  Li et al. show that low-dose decitabine can improve anti–PD-1 efficacy by expanding and functionally sustaining CD8+ progenitor exhausted T cells rather than simply intensifying checkpoint blockade. Their tumor-model and molecular data identify JunD-dependent AP-1 activity as a mechanistic link between epigenetic priming, progenitor-cell proliferation, and tumor control.

• Biotin-XX Tyramide Reagent for Surface Labeling

  2026-09-07

  Biotin-XX Tyramide Reagent combines HRP-driven tyramide signal amplification with a membrane-impermeant linker for selective cell surface protein labeling. This guide translates activity-sensitive proximity-labeling concepts into practical IHC, ISH, fluorescence, and surface-profiling workflows.

• NHS-Biotin for Assays of Multimeric Proteins

  2026-09-05

  NHS-Biotin enables stable amine-reactive labeling, but its greatest analytical value emerges when labeling is treated as a variable in multimeric protein assays. This guide connects N-hydroxysuccinimido biotin chemistry with peptidisc-assisted nanobody engineering and practical assay design.

• MMP7 Drives Liver Fibrosis in Biliary Atresia

  2026-09-04

  A 2026 study identifies MMP7 as a mechanistic driver of biliary atresia-associated liver fibrosis rather than only a diagnostic biomarker. By integrating patient samples, transcriptomic analysis, biliary epithelial cell experiments, and a chronic mouse model, the authors link MMP7 to E-cadherin cleavage, β-catenin nuclear translocation, epithelial–mesenchymal transition, and fibrotic progression.

• Optimizing CS/β-GP/HEC Hydrogels for 3D Culture

  2026-09-04

  Zhao and colleagues used a structured 2 × 2 × 2 factorial design to optimize a chitosan/β-glycerophosphate/hydroxyethyl cellulose hydrogel for injectable, thermoresponsive 3D cell culture. The selected G1 and G3 formulations combined room-temperature injectability with physiological-temperature gelation and supported viable, spatially organized growth of Huh7 cells and bone marrow-derived mesenchymal stem cells.

• UHRF1, Super-Enhancers, and Osteogenesis in SOP

  2026-09-03

  The reference study identifies a mechanistic connection between UHRF1-dependent DNA 5-methylcytosine regulation, super-enhancer redistribution, and TGM2-controlled autophagic flux in senile osteoporosis. Its multi-omics and functional validation strategy links epigenetic remodeling to impaired mesenchymal stem cell osteogenesis and suggests the UHRF1–TGM2 axis as a testable target for age-related bone loss.

• Phosphatase Inhibitor Cocktail 2: Assay Control

  2026-09-03

  Learn how Phosphatase Inhibitor Cocktail 2 supports protein phosphorylation preservation and improves assay interpretation through controlled sample handling, temperature, and orthogonal validation.

8425 records 1/562 page Next 12345 下5页 Last page